Improving quality control for CAR T cell therapies
Drug Discovery World
AUGUST 10, 2022
For example, it is challenging to regulate transgene copy numbers in each T cell, posing safety risks. Although transgenes show a preference for certain sites, the CAR transgene could integrate into the T cell genome at any location, including within a sequence that regulates oncogene expression, thereby increasing cancer risk.
246 
Let's personalize your content